Current status of prostate brachytherapy in Japan.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Histopathological evaluation of local effects of radioactive iodine seeds in axillary lymph nodes in clinically node-positive breast cancer treated with neoadjuvant systemic therapy.Breast (Edinburgh, Scotland) · 2026
   Article
2. Regression Equation for Predicting Source Strength Detection Rate in Iodine-125 Seed Brachytherapy.Cureus · 2026
   Article
3. Verification of Normality in the Source Intensity Detection Rate for Batch Assay Using a Well-Type Ionization Chamber.Cureus · 2025
   Article
4. High Source Strength of Most Blister Packs Delivered for 125I Seed Brachytherapy: A Case Report.Cureus · 2025
   Article
5. Current status and issues with the dosimetric assay of iodine-125 seed sources at medical facilities in Japan: a questionnaire-based survey†.Journal of radiation research · 2023
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.